Compare STRL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | ASND |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | United States | Denmark |
| Employees | 1740 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 14.7B |
| IPO Year | 1996 | 2014 |
| Metric | STRL | ASND |
|---|---|---|
| Price | $533.08 | $222.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $475.50 | $281.50 |
| AVG Volume (30 Days) | 399.6K | ★ 751.0K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.42 | N/A |
| EPS | ★ 9.38 | N/A |
| Revenue | ★ $957,958,000.00 | N/A |
| Revenue This Year | $26.70 | $96.35 |
| Revenue Next Year | $11.63 | $44.91 |
| P/E Ratio | $54.94 | ★ N/A |
| Revenue Growth | ★ 38.81 | N/A |
| 52 Week Low | $163.89 | $151.11 |
| 52 Week High | $521.29 | $250.74 |
| Indicator | STRL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 66.97 | 43.01 |
| Support Level | $280.82 | $214.92 |
| Resistance Level | N/A | $233.88 |
| Average True Range (ATR) | 22.37 | 7.56 |
| MACD | 4.57 | -2.06 |
| Stochastic Oscillator | 95.30 | 16.98 |
Sterling Infrastructure Inc operates through subsidiaries within three segments: E-Infrastructure, Transportation, and Building Solutions in the United States, mainly across the Southern, Northeastern, Mid-Atlantic, and Rocky Mountain regions and the Pacific Islands. E-Infrastructure Solutions generates maximum revenue and provides site development and mission-critical electrical services for data centers, manufacturing, distribution centers, warehousing, and power generation. Transportation Solutions includes infrastructure and rehabilitation projects for highways, airports, ports, rail, and storm drainage systems. Building Solutions includes residential and commercial concrete foundations, parking structures, plumbing services, and surveys for new single-family residential builds.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.